Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · IEX Real-Time Price · USD

2.320

+0.080 (3.57%)

At close: Apr 17, 2024, 4:00 PM

2.271

-0.049 (-2.11%)

After-hours: Apr 17, 2024, 7:27 PM EDT

Adial Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Selling, General & Admin	5.62	8.91	9.34	5.07	4.28	6.62	0.81	0.26
Research & Development	1.27	1.95	8.4	5.85	3.97	0.37	0.18	0.15
Other Operating Expenses	0	0	1.55	0	0	0	0	0
Operating Expenses	6.89	10.86	19.29	10.93	8.24	6.99	1	0.41
Operating Income	-6.89	-10.86	-19.29	-10.93	-8.24	-6.99	-1	-0.41
Interest Expense / Income	0	0	0	0	0	1.17	0.14	0.01
Other Expense / Income	-1.76	1.87	0.23	-0.03	0.35	3.48	-0	-0
Pretax Income	-5.12	-12.73	-19.52	-10.89	-8.59	-11.63	-1.14	-0.42
Income Tax	0	0	-0.09	0	0	0	0	0
Net Income	-5.12	-12.73	-19.42	-10.89	-8.59	-11.63	-1.14	-0.42
Shares Outstanding (Basic)	1	1	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	1	1	0	0	0	0	0
Shares Change	42.25%	34.69%	49.15%	26.50%	107.01%	45.80%	0.20%	-
EPS (Basic)	-3.60	-12.71	-26.00	-21.75	-21.75	-61.00	-8.75	-3.25
EPS (Diluted)	-3.60	-12.71	-26.00	-21.75	-21.75	-61.00	-8.75	-3.25
Free Cash Flow	-6.81	-11.19	-12.01	-7.63	-6.34	-2.5	-0.49	-0.27
Free Cash Flow Per Share	-4.78	-11.17	-16.16	-15.31	-16.08	-13.12	-3.79	-2.10
EBITDA	-5.12	-12.73	-19.46	-10.89	-8.59	-10.46	-0.99	-0.41
Depreciation & Amortization	0	0	0.06	0	0	0	0	0
EBIT	-5.12	-12.73	-19.52	-10.89	-8.59	-10.46	-0.99	-0.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).